Acorda Therapeutics (NASDAQ:ACOR) Receives New Coverage from Analysts at StockNews com
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Acorda Therapeutics (NASDAQ:ACOR) Earns Buy Rating from Analysts at StockNews com
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Acorda Therapeutics (NASDAQ:ACOR) Now Covered by Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Stock analysts at StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “buy” rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Down 24.9 % ACOR stock opened at $0.66 on Friday. The firm has a 50-day moving […]